Home › Calculator › ABT Dividend Calculator 2026
ABT Dividend DRIP Calculator 2026
2.51% YieldHealthcareAbbott Laboratories · NYSE
Price: $98.73 · Annual div: $2.48/share · Frequency: quarterly · Payout ratio: 67% · Ex-div: 2026-10-15
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ABT pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your ABT snowball 📈
$10,000 in ABT → $23.6K in 10 years · $75.36/month
About Abbott Laboratories (ABT) — Dividend Analysis 2026
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Compare ABT with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ABT DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ABT position with:
🌍 ABT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ABT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.51% | -0.29% | $251 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.13% | -0.67% | $213 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.01% | -0.79% | $201 / yr |
| 🇬🇧 UK ISA | 0% | 2.51% | -0.29% | $251 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.29% | -0.51% | $229 / yr |
| 🇨🇦 TFSA | 0% | 2.51% | -0.29% | $251 / yr |
| 🇨🇦 CA Taxable | 25% | 1.88% | -0.92% | $188 / yr |
| 🇦🇺 Super (pension) | 15% | 2.13% | -0.67% | $213 / yr |
| 🇦🇺 AU Taxable | 30% | 1.76% | -1.04% | $176 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.85% | -0.95% | $185 / yr |
| 🇫🇷 FR Taxable | 30% | 1.76% | -1.04% | $176 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ABT Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.48/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ABT Dividend Payment Schedule
ABT pays quarterly — 4 times per year. Ex-div: 2026-10-15.
📊 ABT vs Healthcare Benchmarks
How ABT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ABT sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ABT Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-09-30 | 397 | — | — | ||
| A-Award | 2026-09-30 | 333 | — | — | ||
| A-Award | 2026-09-30 | 318 | — | — | ||
| A-Award | 2026-09-30 | 318 | — | — | ||
| A-Award | 2026-09-30 | 381 | — | — | ||
| F-InKind | 2026-09-23 | 52,507 | $103.99 | $5.46M | ||
| F-InKind | 2026-09-01 | 52 | $110.36 | $5.7K | ||
| Sale | 2026-09-02 | 27 | $109.54 | $3.0K | ||
| F-InKind | 2026-09-01 | 388 | $110.36 | $42.8K | ||
| M-Exempt | 2026-08-25 | 246,963 | $59.94 | $14.80M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare ABT with peers: ABT vs BSX · ABT vs GILD · ABT vs ISRG
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where ABT earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ABT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Abbott Laboratories (ABT) is currently trading at $98.73, 27% below its 52-week high. The current dividend yield is 2.51% based on an annual payout of $2.48 per share.
Abbott Laboratories Offers a Reliable Yield Backed by Strong Dividend Growth
AI SummaryAbbott Laboratories is a premier healthcare giant with a $170.8B market cap, offering a 2.51% dividend yield backed by an annual payout of $2.48. The company demonstrates solid dividend safety with a sustainable 67% payout ratio, ensuring ample earnings coverage to maintain and grow distributions. Income-focused investors will find its financial health and robust market position reassuring for long-term holding. Demonstrating an impressive 5-year dividend CAGR of 10.3%, Abbott exhibits a strong growth trajectory that outpaces many sector peers. While its current P/E ratio of 26.5 suggests a premium valuation, this reflects the company's consistent operational execution and diversified medical portfolio. Overall, the fundamental metrics indicate a healthy and enduring dividend profile.
- Premium valuation with a 26.5 P/E ratio leaves little room for operational missteps
- Potential macroeconomic pressures impacting healthcare spending and device demand
Generated by AI using live market data. For educational purposes only — not financial advice.
Latest ABT News
LiveHow investors use the ABT dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.